Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000919574-24-006855
Filing Date
2024-11-21
Accepted
2024-11-21 20:05:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 d11534381_13d-a.htm SC 13D/A 102244
  Complete submission text file 0000919574-24-006855.txt   104101
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Subject) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42290 | Film No.: 241486041
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address BROADWOOD CAPITAL INC. 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019
Business Address BROADWOOD CAPITAL INC. 156 WEST 56TH STREET, 3RD FLOOR NEW YORK NY 10019 212-508-5735
BROADWOOD PARTNERS, L.P. (Filed by) CIK: 0001278386 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A